2.03% -0.1173

アフターアワーズ： 5.67

Serina Therapeutics Inc (SER)

概要ニュース株価時系列ディスカッション予測

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics to Present at JonesResearch Virtual CNS Day - The Manila Times

Serina Therapeutics CEO to Showcase Revolutionary CNS Drug Technology: Key Presentation Details Revealed - Stock Titan

Serina Therapeutics Says May Offer And Sell Shares Of Common Stock Of Up To $13.3 Million - marketscreener.com

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - The Globe and Mail

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit - GlobeNewswire

Revolutionary Drug Delivery Tech Could Make mRNA Vaccines Safer: New Trial Data - Stock Titan

Serina Therapeutics closes $5 million funding for Parkinson’s trial By Investing.com - Investing.com Canada

Serina Therapeutics Secures $5 Million Funding - MarketScreener

Serina Therapeutics closes $5 million funding for Parkinson’s trial - Investing.com

Serina Therapeutics Secures $5 Million in Funding to - GlobeNewswire

Revolutionary Parkinson's Treatment Gets $5M Boost: Serina's New Drug Heads to Clinical Trials - Stock Titan

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewswire

Serina's Game-Changing POZ Platform Takes Center Stage at Major Healthcare Conference - Stock Titan

Serina Therapeutics Files For Mixed Shelf Of Upto $100 MillionSEC Filing - MarketScreener

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Serina Therapeutics to Present Novel Data on Non-Immunogenic Lipid Nanoparticles at ACS Spring 2025 Meeting - Nasdaq

Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting - GlobeNewswire

Serina Cuts $11.2M Debt, Secures $10M Investment While Revenue Drops 98% - Stock Titan

Jones Trading Initiates Coverage of Serina Therapeutics (SER) with Buy Recommendation - Nasdaq

Serina Therapeutics initiated with a Buy at JonesResearch - TipRanks

Serina Therapeutics Appoints Dr. Venkatesan to Board - TipRanks

Serina Therapeutics Appoints Dr. Jay Venkatesan to Board of Directors - Nasdaq

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewswire

Former Alpine Immune Sciences Founder Who Led $4.9B Exit Takes Board Seat at Serina - StockTitan

Huntsville biotech firm partnering with Pfizer lands $10 million for Parkinson’s trial - MSN

Serina secures additional $5 million for Parkinson's trial - MSN

Serina secures additional $5 million for Parkinson's trial By Investing.com - Investing.com Australia

Stocks to Watch: Palantir Technologies, Synaptics, J&J Snack Foods, Serina Therapeutics - MarketWatch

Serina Therapeutics's Shares Up Following $5M of Equity Financing - MarketWatch

Serina Therapeutics Receives Second $5 Mln Tranche To Strengthen Cash Position - Marketscreener.com

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Serina Therapeutics receives funding to advance SER-252 into clinical trial - TipRanks

Serina Therapeutics Secures $5 Million for SER-252 Trials - TipRanks

Serina Therapeutics Receives Second $5 Million Tranche to - GlobeNewswire

Parkinson's Breakthrough: Serina Therapeutics Lands Premium-Priced $5M Investment to Advance Novel Treatment - StockTitan

Serina Therapeutics Secures Additional $5 Million Financing to Advance SER-252 into Phase 1 Trial for Advanced Parkinson's Disease - Nasdaq

Stocks to Watch: Serina Therapeutics, Powell Max, Silexion Therapeutics - MarketWatch

Serina Therapeutics Shares Rise After Sale of UniverXome Subsidiary - MarketWatch

Serina Therapeutics Sells UniverXome Subsidiary - MarketWatch

Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewswire

Serina Therapeutics Achieves Debt-Free Status After $11.2M UniverXome Sale, Sharpens Focus on Parkinson's Drug - StockTitan

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewswire

Serina Therapeutics, Inc. Appoints Karen J. Wilson to its Board of Directors -January 14, 2025 at 05:25 pm EST - Marketscreener.com

Serina Therapeutics director Bailey Gregory buys shares worth $17,744 By Investing.com - Investing.com Australia

Serina Therapeutics director Bailey Gregory buys shares worth $17,744 - Investing.com

Serina Therapeutics expands equity incentive plan By Investing.com - Investing.com Australia

Serina Therapeutics expands equity incentive plan - Investing.com India

Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - The Globe and Mail

Serina Therapeutics to Present at Tribe Public’s Webinar - GlobeNewswire

Serina Therapeutics to Unveil Breakthrough Parkinson's Treatment Strategy in Upcoming Webinar - StockTitan

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewswire

SERに似た銘柄